109 related articles for article (PubMed ID: 30706477)
21. Reciprocal and coordinate regulation of serum amyloid A versus apolipoprotein A-I and paraoxonase-1 by inflammation in murine hepatocytes.
Han CY; Chiba T; Campbell JS; Fausto N; Chaisson M; Orasanu G; Plutzky J; Chait A
Arterioscler Thromb Vasc Biol; 2006 Aug; 26(8):1806-13. PubMed ID: 16709944
[TBL] [Abstract][Full Text] [Related]
22. Regulation of expression of apolipoprotein A-I by selenium status in human liver hepatoblastoma cells.
Stahle JA; Vunta H; Channa Reddy C; Sandeep Prabhu K
Eur J Nutr; 2009 Aug; 48(5):283-90. PubMed ID: 19294445
[TBL] [Abstract][Full Text] [Related]
23. Sodium Propionate or Sodium Butyrate Promotes Fatty Acid Oxidation in HepG2 Cells Under Oxidative Stress.
Cook KJ; Coulter A; Keenan M; Greenway F; Losso JN
J Med Food; 2023 Jan; 26(1):74-79. PubMed ID: 36637439
[TBL] [Abstract][Full Text] [Related]
24. Tumor necrosis factor α stimulates endogenous apolipoprotein A-I expression and secretion by human monocytes and macrophages: role of MAP-kinases, NF-κB, and nuclear receptors PPARα and LXRs.
Shavva VS; Mogilenko DA; Nekrasova EV; Trulioff AS; Kudriavtsev IV; Larionova EE; Babina AV; Dizhe EB; Missyul BV; Orlov SV
Mol Cell Biochem; 2018 Nov; 448(1-2):211-223. PubMed ID: 29442267
[TBL] [Abstract][Full Text] [Related]
25. Paradoxical exacerbation of combined hyperlipidemia in human apolipoprotein A-II transgenic mice treated with fenofibrate.
Ribas V; Palomer X; Roglans N; Rotllan N; Fievet C; Tailleux A; Julve J; Laguna JC; Blanco-Vaca F; Escolà-Gil JC
Biochim Biophys Acta; 2005 Dec; 1737(2-3):130-7. PubMed ID: 16226489
[TBL] [Abstract][Full Text] [Related]
26. Differentiated CaCo-2 cells as an in-vitro model to evaluate de-novo apolipoprotein A-I production in the small intestine.
Dullens SP; Mensink RP; Mariman EC; Plat J
Eur J Gastroenterol Hepatol; 2009 Jun; 21(6):642-9. PubMed ID: 19445040
[TBL] [Abstract][Full Text] [Related]
27. Beneficial effects of fibrates on apolipoprotein A-I metabolism occur independently of any peroxisome proliferative response.
Hennuyer N; Poulain P; Madsen L; Berge RK; Houdebine LM; Branellec D; Fruchart JC; Fiévet C; Duverger N; Staels B
Circulation; 1999 May; 99(18):2445-51. PubMed ID: 10318668
[TBL] [Abstract][Full Text] [Related]
28. Relationship between peroxisome proliferator-activated receptor alpha activity and cellular concentration of 14 perfluoroalkyl substances in HepG2 cells.
Rosenmai AK; Ahrens L; le Godec T; Lundqvist J; Oskarsson A
J Appl Toxicol; 2018 Feb; 38(2):219-226. PubMed ID: 28857218
[TBL] [Abstract][Full Text] [Related]
29. Elevated homocysteine reduces apolipoprotein A-I expression in hyperhomocysteinemic mice and in males with coronary artery disease.
Mikael LG; Genest J; Rozen R
Circ Res; 2006 Mar; 98(4):564-71. PubMed ID: 16439690
[TBL] [Abstract][Full Text] [Related]
30. The protein kinase C signaling pathway regulates a molecular switch between transactivation and transrepression activity of the peroxisome proliferator-activated receptor alpha.
Blanquart C; Mansouri R; Paumelle R; Fruchart JC; Staels B; Glineur C
Mol Endocrinol; 2004 Aug; 18(8):1906-18. PubMed ID: 15131257
[TBL] [Abstract][Full Text] [Related]
31. Induction of apolipoprotein A-I gene expression by black seed (Nigella sativa) extracts.
Haas MJ; Onstead-Haas LM; Naem E; Wong NC; Mooradian AD
Pharm Biol; 2014 Sep; 52(9):1119-27. PubMed ID: 24635344
[TBL] [Abstract][Full Text] [Related]
32. Hugan Qingzhi medication ameliorates hepatic steatosis by activating AMPK and PPARα pathways in L02 cells and HepG2 cells.
Yin J; Luo Y; Deng H; Qin S; Tang W; Zeng L; Zhou B
J Ethnopharmacol; 2014 May; 154(1):229-39. PubMed ID: 24735863
[TBL] [Abstract][Full Text] [Related]
33. Suppression of plasma free fatty acids upregulates peroxisome proliferator-activated receptor (PPAR) alpha and delta and PPAR coactivator 1alpha in human skeletal muscle, but not lipid regulatory genes.
Watt MJ; Southgate RJ; Holmes AG; Febbraio MA
J Mol Endocrinol; 2004 Oct; 33(2):533-44. PubMed ID: 15525607
[TBL] [Abstract][Full Text] [Related]
34. Fibrate-modulated expression of fibrinogen, plasminogen activator inhibitor-1 and apolipoprotein A-I in cultured cynomolgus monkey hepatocytes -- role of the peroxisome proliferator-activated receptor-alpha.
Kockx M; Princen HM; Kooistra T
Thromb Haemost; 1998 Dec; 80(6):942-8. PubMed ID: 9869165
[TBL] [Abstract][Full Text] [Related]
35. Role of PPARα in the attenuation of bile acid-induced apoptosis by omega-3 long-chain polyunsaturated fatty acids in cultured hepatocytes.
Tillman EM; Guan P; Howze TJ; Helms RA; Black DD
Pediatr Res; 2016 May; 79(5):754-8. PubMed ID: 26756785
[TBL] [Abstract][Full Text] [Related]
36. An experimental study on amelioration of dyslipidemia-induced atherosclesis by Clematichinenoside through regulating Peroxisome proliferator-activated receptor-α mediated apolipoprotein A-I, A-II and C-III.
Liu C; Guo Q; Lu M; Li Y
Eur J Pharmacol; 2015 Aug; 761():362-74. PubMed ID: 25979856
[TBL] [Abstract][Full Text] [Related]
37. [Association between peroxisome proliferator-activated receptor and gene-gene interactions with the apolipoprotein A I/apolipoprotein B100 ratio].
Hai B; Ni C; Xie H; Guo Z; Wu M; Chen Q; Zhou Z; Fan W; Zhou H
Zhonghua Xin Xue Guan Bing Za Zhi; 2015 Apr; 43(4):328-33. PubMed ID: 26082365
[TBL] [Abstract][Full Text] [Related]
38. Ginsenoside Rf, a component of ginseng, regulates lipoprotein metabolism through peroxisome proliferator-activated receptor alpha.
Lee H; Gonzalez FJ; Yoon M
Biochem Biophys Res Commun; 2006 Jan; 339(1):196-203. PubMed ID: 16297877
[TBL] [Abstract][Full Text] [Related]
39. Cyclin D1 represses peroxisome proliferator-activated receptor alpha and inhibits fatty acid oxidation.
Kamarajugadda S; Becker JR; Hanse EA; Mashek DG; Mashek MT; Hendrickson AM; Mullany LK; Albrecht JH
Oncotarget; 2016 Jul; 7(30):47674-47686. PubMed ID: 27351284
[TBL] [Abstract][Full Text] [Related]
40. Administration of a PPARalpha agonist increases serum apolipoprotein A-V levels and the apolipoprotein A-V/apolipoprotein C-III ratio.
Schultze AE; Alborn WE; Newton RK; Konrad RJ
J Lipid Res; 2005 Aug; 46(8):1591-5. PubMed ID: 15897610
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
